RedHill Biopharma (RDHL) Exchange Rate Effect (2016 - 2022)
Historic Exchange Rate Effect for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to -$16000.0.
- RedHill Biopharma's Exchange Rate Effect fell 27777.78% to -$16000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$76000.0, marking a year-over-year increase of 2164.95%. This contributed to the annual value of $9000.0 for FY2024, which is 14090.91% up from last year.
- RedHill Biopharma's Exchange Rate Effect amounted to -$16000.0 in Q4 2022, which was down 27777.78% from -$13000.0 recorded in Q3 2022.
- RedHill Biopharma's Exchange Rate Effect's 5-year high stood at $131000.0 during Q1 2020, with a 5-year trough of -$103000.0 in Q1 2021.
- For the 5-year period, RedHill Biopharma's Exchange Rate Effect averaged around -$2650.0, with its median value being -$13500.0 (2018).
- Over the last 5 years, RedHill Biopharma's Exchange Rate Effect had its largest YoY gain of 71875.0% in 2020, and its largest YoY loss of 340000.0% in 2020.
- RedHill Biopharma's Exchange Rate Effect (Quarter) stood at -$16000.0 in 2018, then skyrocketed by 437.5% to $54000.0 in 2019, then tumbled by 83.33% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then tumbled by 277.78% to -$16000.0 in 2022.
- Its Exchange Rate Effect was -$16000.0 in Q4 2022, compared to -$13000.0 in Q3 2022 and -$32000.0 in Q2 2022.